Biosintez will launch its new production facility in September 2018

Today, Biosintez PJSC is one of the largest Russian full-cycle pharmaceutical manufacturers. Its products range from substances to finished medicines, including tablets, ointments, suppositories, powders for injections, injection and infusion solutions.

The company has ISO 9001:2008 quality management system and environmental management system. Its range of products includes more than 190 drugs of various pharmacological therapeutic groups. 70% of manufactured medicines are from the list of vital and essential drugs.


Currently, the company is completing the construction of its new production site. It has an area of 7 thousand square meters and is designed to produce at least 2 billion tablets a year.


Production line is a high-tech facility that provides special conditions for manufacturing medicinal products. The premises feature modern equipment and special climate control units that can limit the content of particles and microorganisms in accordance with the established requirements.

About 80 percent of new facility is already completed, and its launch is scheduled for September 2018.